DTC Genetics Services Hit Hard on the Hill as FDA Mulls Options | GenomeWeb

By Matt Jones

NEW YORK (GenomeWeb News) – Three consumer genomics companies caught flak on Capitol Hill yesterday from lawmakers and government witnesses at a hearing focused on direct-to-consumer genetic tests and the way they are sold and marketed — and they heard about very germ-phase plans the US Food and Drug Administration may be developing to find ways to regulate them.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.